This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Hepatitis


  • Hepatitis B Continues to be a Global Health Problem
    Hepatitis B infections are among the most common infectious diseases worldwide. The disease can become chronic, and is one of the most important causes of severe diseases such as liver cancer. In the scope of an international study funded by the World Health Organization, ...More
    3 days ago Posted in News
  • FDA Approves New Treatment for Chronic Hepatitis C Genotype 3 Infections
    The Food and Drug Administration (FDA) has approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without the ...More
    1 week ago Posted in News
  • WHO Calls for Urgent Action to Curb Hepatitis
    On World Hepatitis Day, July 28, 2015, the World Health Organization (WHO) highlights the urgent need for countries to enhance action to prevent viral hepatitis infection and to ensure that people who have been infected are diagnosed and offered treatment. This year, ...More
    1 week ago Posted in News
  • Experts Urge Transplantation of Hepatitis C-Infected Kidneys in Some Non-Infected Patients
    The average wait time for a kidney transplant is five years and there are more than 100,000 people on the waiting list. However, there are thousands of viable hepatitis C-positive kidneys that are discarded each year solely because they’re infected. A new perspective ...More
    2 weeks ago Posted in News
  • New Drug Combination Treats Hepatitis C Patients Also Infected With HIV
    Roughly 20 percent to 30 percent of patients with hepatitis C virus (HCV) are also infected with human immunodeficiency virus type 1 (HIV). Both bloodborne viruses share the same modes of transmission, but many HCV medications currently have significant limitations due to ...More
    2 weeks ago Posted in News
  • AASLD Updates Guidance for Use of Hepatitis C Drugs
    The American Association for the Study of Liver Diseases (AASLD), in partnership with the Infectious Diseases Society of America (IDSA) and in collaboration with the International Antiviral Society-USA (IAS-USA), created online Recommendations for Testing, Managing, and ...More
    June 25, 2015 Posted in News
  • Risk of Hepatitis E Outbreak in Earthquake-Ravaged Nepal is Significant, Experts Say
    During the coming monsoon season, survivors of the recent earthquake that destroyed parts of Nepal face a “very high” risk of a hepatitis E outbreak that could be especially deadly to pregnant women, according to a consensus statement from a group of infectious ...More
    June 16, 2015 Posted in News
  • Hepatitis B Vaccine Less Effective in Rheumatoid Arthritis Patients
    The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that people with rheumatoid arthritis (RA) are less likely to be protected by hepatitis B vaccination than the general population. Within the trial only 11 ...More
    June 12, 2015 Posted in News
  • FDA Addresses Concerns on Approval of Drugs to Treat Chronic Hepatitis C
    Treatment options for chronic hepatitis C, a serious and life-threatening infection, have improved substantially and several new regimens with shorter durations and improved efficacy and safety profiles are now available. Groups have raised concerns about the evidence used ...More
    June 2, 2015 Posted in News
« Previous12345678910115758Next »